| 11/16/2026 4:06 PM | Nurix Therapeutics (1549595) Subject PERCEPTIVE ADVISORS LLC (1224962) Filed by | Form SCHEDULE 13G/A | |
| 11/16/2026 3:20 PM | Nurix Therapeutics (1549595) Subject Vestal Point Capital, LP (1974915) Filed by | Form SCHEDULE 13G/A | |
| 11/16/2026 9:00 AM | Nurix Therapeutics (1549595) Subject PRICE T ROWE ASSOCIATES INC /MD/ (80255) Filed by | Form SCHEDULE 13G/A | |
| 11/16/2026 7:44 AM | Deep Track Capital, LP (1856083) Filed by Nurix Therapeutics (1549595) Subject | Form SCHEDULE 13G/A | |
| 11/05/2026 12:22 PM | FMR LLC (315066) Filed by Nurix Therapeutics (1549595) Subject | Form SCHEDULE 13G/A | |
| 11/04/2026 4:03 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2026 4:05 PM | Nurix Therapeutics (1549595) Issuer van Houte Hans (1817217) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2026 3:24 PM | Nurix Therapeutics (1549595) Subject van Houte Hans (1817217) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/03/2026 3:26 PM | Nurix Therapeutics (1549595) Subject Ring Christine (1817199) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/02/2026 6:44 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/02/2026 6:47 PM | Nurix Therapeutics (1549595) Issuer van Houte Hans (1817217) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NRIX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nurix Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 11/02/2026 6:42 PM | Hansen Gwenn (1817160) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/15/2026 4:00 PM | Hansen Gwenn (1817160) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/14/2026 3:11 PM | GREGORY JULIA P (1226675) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/14/2026 3:14 PM | GREGORY JULIA P (1226675) Reporting Nurix Therapeutics (1549595) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/13/2026 5:19 AM | Nurix Therapeutics (1549595) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/13/2026 5:21 AM | Nurix Therapeutics (1549595) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/02/2026 4:21 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2026 3:19 PM | Nurix Therapeutics (1549595) Subject Ring Christine (1817199) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/23/2026 3:30 PM | Nurix Therapeutics (1549595) Subject PERCEPTIVE ADVISORS LLC (1224962) Filed by | Form SCHEDULE 13G | |
| 09/02/2026 6:42 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2026 3:30 PM | Nurix Therapeutics (1549595) Subject Ring Christine (1817199) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/01/2026 4:19 PM | Hansen Gwenn (1817160) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 9:38 AM | Nurix Therapeutics (1549595) Subject PRICE T ROWE ASSOCIATES INC /MD/ (80255) Filed by | Form SCHEDULE 13G | |
| 08/14/2026 7:36 AM | Deep Track Capital, LP (1856083) Filed by Nurix Therapeutics (1549595) Subject | Form SCHEDULE 13G/A | |
| 08/05/2026 5:59 PM | Hansen Gwenn (1817160) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2026 5:39 AM | Hansen Gwenn (1817160) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/04/2026 8:41 PM | Nurix Therapeutics (1549595) Issuer van Houte Hans (1817217) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/04/2026 3:33 PM | Nurix Therapeutics (1549595) Subject van Houte Hans (1817217) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/04/2026 3:34 PM | Hansen Gwenn (1817160) Reporting Nurix Therapeutics (1549595) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/03/2026 4:51 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/31/2026 9:42 AM | Nurix Therapeutics (1549595) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 07/30/2026 4:56 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/30/2026 4:58 PM | Nurix Therapeutics (1549595) Issuer van Houte Hans (1817217) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/30/2026 4:50 PM | Hansen Gwenn (1817160) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2026 3:09 PM | Nurix Therapeutics (1549595) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/09/2026 3:12 PM | Nurix Therapeutics (1549595) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/02/2026 5:02 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2026 5:38 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2026 5:49 PM | Hansen Gwenn (1817160) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2026 3:24 PM | Hansen Gwenn (1817160) Reporting Nurix Therapeutics (1549595) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Today's free pick (on me) (Ad) Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company.
With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th. Get today's free pick before December 8th. |
| 06/25/2026 3:24 PM | Nurix Therapeutics (1549595) Subject Ring Christine (1817199) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/11/2026 6:06 AM | Nurix Therapeutics (1549595) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/08/2026 5:11 AM | Nurix Therapeutics (1549595) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/02/2026 6:14 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 3:34 PM | Nurix Therapeutics (1549595) Subject Ring Christine (1817199) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/15/2026 4:52 PM | Nurix Therapeutics (1549595) Issuer Reinsdorf Judith A (1305361) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 4:55 PM | Nurix Therapeutics (1549595) Issuer Saltzman Edward C (1946233) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 4:56 PM | Nurix Therapeutics (1549595) Issuer Silva Paul M (1446372) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 4:37 PM | GREGORY JULIA P (1226675) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 4:42 PM | Baynes Roy D. (1680739) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 4:46 PM | DANSEY ROGER D (1741836) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 4:49 PM | Kapur Anil (1730703) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 4:51 PM | Lacey David L. (1734422) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 4:01 PM | Nurix Therapeutics (1549595) Subject Vestal Point Capital, LP (1974915) Filed by | Form SCHEDULE 13G | |
| 05/15/2026 3:03 PM | Nurix Therapeutics (1549595) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 7:45 AM | Deep Track Capital, LP (1856083) Filed by Nurix Therapeutics (1549595) Subject | Form SCHEDULE 13G/A | |
| 05/06/2026 10:30 AM | FMR LLC (315066) Filed by Nurix Therapeutics (1549595) Subject | Form SCHEDULE 13G | |
| 05/05/2026 6:53 PM | Nurix Therapeutics (1549595) Issuer van Houte Hans (1817217) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 5:10 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 4:50 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 3:49 PM | Nurix Therapeutics (1549595) Subject Ring Christine (1817199) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/30/2026 4:37 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/30/2026 4:38 PM | Nurix Therapeutics (1549595) Issuer van Houte Hans (1817217) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/30/2026 4:35 PM | Hansen Gwenn (1817160) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 8:28 PM | Nurix Therapeutics (1549595) Subject Redmile Group, LLC (1425738) Filed by | Form SCHEDULE 13G/A | |
| 04/08/2026 5:02 AM | Nurix Therapeutics (1549595) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/08/2026 5:03 AM | Nurix Therapeutics (1549595) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/02/2026 6:02 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 10:09 AM | Nurix Therapeutics (1549595) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/27/2026 5:03 AM | Nurix Therapeutics (1549595) Filer | Form DEF 14A | |
| 03/27/2026 5:04 AM | Nurix Therapeutics (1549595) Filer | Form DEFA14A | |
| 03/27/2026 5:04 AM | Nurix Therapeutics (1549595) Filer | Form ARS | |
| 03/06/2026 3:38 PM | Nurix Therapeutics (1549595) Filer | Form 424B5 | |
| 03/06/2026 3:40 PM | Nurix Therapeutics (1549595) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/02/2026 6:05 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 3:33 PM | Nurix Therapeutics (1549595) Subject Ring Christine (1817199) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/10/2026 5:09 PM | Nurix Therapeutics (1549595) Issuer van Houte Hans (1817217) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/10/2026 4:43 PM | Nurix Therapeutics (1549595) Issuer SANDS ARTHUR T (1134106) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/10/2026 4:50 PM | Hansen Gwenn (1817160) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/10/2026 4:55 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 6:47 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 8:12 PM | Hansen Gwenn (1817160) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/30/2026 7:36 PM | Hansen Gwenn (1817160) Reporting Nurix Therapeutics (1549595) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/30/2026 7:38 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/30/2026 7:39 PM | Nurix Therapeutics (1549595) Issuer van Houte Hans (1817217) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/28/2026 3:09 PM | Nurix Therapeutics (1549595) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 01/28/2026 3:18 PM | Nurix Therapeutics (1549595) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 01/20/2026 6:57 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 7:34 AM | Nurix Therapeutics (1549595) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/18/2025 5:08 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Your free book is about to disappear (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link.
He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes |
| 12/18/2025 3:21 PM | Nurix Therapeutics (1549595) Subject Ring Christine (1817199) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/09/2025 5:05 AM | Nurix Therapeutics (1549595) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/24/2025 5:06 PM | Nurix Therapeutics (1549595) Issuer Ring Christine (1817199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 3:27 PM | Nurix Therapeutics (1549595) Subject Ring Christine (1817199) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |